Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors
Authors:
- 15 March 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (6) , 1719-1723
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) InhibitorsJournal of Medicinal Chemistry, 2009
- Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38Journal of Biological Chemistry, 2009
- Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Inhibitors of c-jun-N-Terminal Kinase (JNK)Mini-Reviews in Medicinal Chemistry, 2008
- AS601245, a c‐Jun NH2‐terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbilsBritish Journal of Pharmacology, 2008
- 3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3Bioorganic & Medicinal Chemistry Letters, 2007
- Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase ActivityJournal of Medicinal Chemistry, 2006
- Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3Bioorganic & Medicinal Chemistry Letters, 2006